Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind
April 09, 2025
From CNBC.com News
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
April 04, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
April 01, 2025
From CNBC.com News
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
From CNBC.com News
5 things to know before the stock market opens Tuesday
March 25, 2025
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
March 24, 2025
From CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
March 24, 2025
From CNBC.com News
Zepbound copycats remain online despite FDA ban
March 21, 2025
From CNBC.com News
From CNBC.com News
Tickers
CEOS
From CNBC.com News
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
March 05, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
February 25, 2025
From CNBC.com News
From CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
February 20, 2025
From CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
From CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.